David Rodriguez, M.S. (he/him/his)

BASF Corporation

Poster(s):

• (M1230-03-20) Drug Product Attributes as an Effect of Formulation Composition of Vardenafil HCl Tablets Produced by the Mixture of the Coprocessed Excipient versus a Similar Spray-Dried Lactose Blend
  Monday, October 23, 2023

  12:30 PM – 1:30 PM ET

• (M1230-12-82) Impact of Extra Components Added to an All-in-One Coprocessed Excipient to Obtain a Better Processability of Cohesive and Poor Flowing Hydrochlorothiazide
  Monday, October 23, 2023

  12:30 PM – 1:30 PM ET

• (T1330-03-20) Orally Disintegrating Tablet Formulation of Vardenafil Taste-Masked Pellets
  Tuesday, October 24, 2023

  1:30 PM – 2:30 PM ET